Extrarenal sequential organ failure assessment score as an outcome predictor of critically ill children on continuous renal replacement therapy

2014 ◽  
Vol 29 (6) ◽  
pp. 1089-1095 ◽  
Author(s):  
Won Kyoung Jhang ◽  
Young A. Kim ◽  
Eun Ju Ha ◽  
Yoon Jung Lee ◽  
Ju Hoon Lee ◽  
...  
2021 ◽  
Vol 8 (10) ◽  
pp. 1684
Author(s):  
Naresh Kumar N. ◽  
Suresh Chelliah D. ◽  
Senguttuvan D.

Background: The objective of the study was to assess prognostic accuracy of SOFA (sequential organ failure assessment score) and Q-SOFA (quick-sequential organ failure assessment) score in detecting morbidity and mortality in critically ill children admitted in our intensive care unit.Methods: All critically ill children admitted were recruited over a time period of 7 months. Q-SOFA score was assessed at presentation, followed by SOFA score on day 1 and day 2 of ICU stay and outcome was observed.Results: Total of 272 sick children were recruited and assessed. All eight (2.94%) mortalities had high Q-SOFA score of three (p<0.001), mean SOFA (day 1) score 11.12±0.99 (p<0.001), mean SOFA (day 2) was 11.62±1.40 (p<0.001).Conclusions: Q-SOFA is a simple, inexpensive and rapid test to assess and predict sick children requiring ICU care in emergency department. High SOFA score predicts high probability of mortality and detects organ failure early.


2020 ◽  
Vol 44 (1) ◽  
pp. 17-24
Author(s):  
Nuttha Lumlertgul ◽  
Nattachai Srisawat

Excessive pro-inflammatory and anti-inflammatory cytokines are mediators for haemodynamic alterations, metabolic acidosis, and multi-organ failure in sepsis. Recently, oXiris® haemofilter (Baxter, IL, USA) has been introduced as a novel haemofilter to mitigate inflammatory response during sepsis-associated acute kidney injury requiring renal replacement therapy. In the present case series, the researchers retrospectively reviewed critically ill patients with septic shock with the use of at least one oXiris haemofilter during continuous renal replacement therapy between June 2015 and December 2017. The timing for oXiris initiation was at the nephrologists’ discretion. The impact of oXiris haemofilter was evaluated on mean arterial pressure, vasopressor dosage, Sequential Organ Failure Assessment score, lactate and base excess during 72 h after treatment. Thirty-five patients were enrolled in the study. An improvement of haemodynamic status was found, shown by increased mean arterial pressure by 6.1% ( p = 0.35), decreased norepinephrine dose by 45.9% ( p = 0.02), inotropic score by 26.4% ( p = 0.02) and vasopressor dependency index by 40.5% ( p = 0.01). Cardiovascular Sequential Organ Failure Assessment scores significantly decreased over 72 h ( p = 0.02). Blood lactate levels and base excess also showed statistically significant improvements. The median filter lifetime was 23 (interquartile range = 14–36) hours. The intensive care unit mortality was 82.9%. Treatment with oXiris was safe and well-tolerated with no device-related adverse events. In conclusion, continuous renal replacement therapy with oXiris haemofilter is safe and may improve haemodynamic parameters in septic patients with severe renal dysfunction. Nonetheless, these findings were drawn from a retrospective analysis without a control group, and therefore cannot be generalised. Randomised controlled trials are warranted to confirm these findings.


2018 ◽  
Vol 33 (6) ◽  
pp. 1079-1085 ◽  
Author(s):  
Matthew F. Barhight ◽  
Jennifer Lusk ◽  
John Brinton ◽  
Timothy Stidham ◽  
Danielle E. Soranno ◽  
...  

2019 ◽  
Vol 20 (4) ◽  
pp. 314-322 ◽  
Author(s):  
Gerard Cortina ◽  
Rosemary McRae ◽  
Monsurul Hoq ◽  
Susan Donath ◽  
Roberto Chiletti ◽  
...  

2009 ◽  
Vol 35 (4) ◽  
pp. 698-706 ◽  
Author(s):  
Michael Zappitelli ◽  
Marisa Juarez ◽  
L. Castillo ◽  
Jorge Coss-Bu ◽  
Stuart L. Goldstein

Sign in / Sign up

Export Citation Format

Share Document